Prevention of preterm birth in women at risk identified by ultrasound: evaluation of two treatment strategies.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-000241-13-ES

Enrollment

Unknown

Registered

2012-02-10

Start date

2012-04-13

Completion date

Unknown

Last updated

2016-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: PROGEFFIK Pharmaceutical Form: Capsule, soft INN or Proposed INN: PROGESTERONE CAS Number: 57-83-0 Current Sponsor code: pro Concentration unit: mg milligram(s) Concentration type: equal C

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 600 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Spain

Contacts

Public ContactLourdes Caberera

Servico de Farmacologia Clínica

lcabrera.hpth@salud.madrid.org0034911917479

Outcome results